IHC 72
Latest Information Update: 30 May 2001
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 26 Mar 1997 No-Development-Reported for Arrhythmias in China (Unknown route)
- 24 Oct 1994 Preclinical development for Arrhythmias in China (Unknown route)